期刊文献+

血管生成素-1和血管生成素-2在先天性心脏病肺动脉高压形成中的变化和意义 被引量:2

Changes and significance of angiopoietin-1 and angiopoietin-2 in congenital heart disease-induced pulmonary arterial hypertension
下载PDF
导出
摘要 目的研究血管生成素-1(angiopoietin-1)和血管生成素-2(angiopoietin-2)在先天性心脏病肺动脉高压形成过程中的变化和意义。方法 42例先天性心脏病手术患者根据术中肺动脉测压结果,分为先心病不伴有肺动脉高压组(16例),先心病伴轻度肺动脉高压组(15例)和先心病伴中重度肺动脉高压组(11例)。8例因肺大疱行肺叶楔形切除术的患者为正常对照组。对患者肺组织内angiopoietin-1、angiopoietin-2、Tie2和激活型caspase-3进行检测。结果先心病伴肺动脉高压患者肺微细动脉内膜内皮细胞肥大增生。先心病伴轻度肺动脉高压组和先心病伴中重度肺动脉高压组angiopoietin-1和Tie2的表达逐渐升高。肺动脉高压患者肺组织内Tie2的磷酸化也逐渐增加,但激活型caspase-3却明显降低。结论内皮细胞凋亡减少可能是先心病肺动脉高压形成中一个重要的病理机制。angiopoietin-1/Tie2系统可能通过抑制内皮细胞凋亡,促进体-肺分流肺动脉高压的形成。然而在这个过程中angiopoietin-2可能并不起明显的作用。 [Objective] To elucidate possible roles of angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) in the development of congenital heart disease-induced pulmonary arterial hypertension (PAH). [ Methods ] Forty-two pa- tients with congenital heart disease (CHD) who underwent cardiac surgery were enrolled in the study. Patients were separated into 3 groups as CHD without PAH (16 patients), CHD with mild PAH (15 patients) and CHD with moderate and severe PAH (11 patients) on the evaluation of pulmonary pressure. Eight patients with normal lung histology who underwent wedge resection of the lung because of pulmonary bullae were studied as control patients. Ang-1, Ang-2, Tie2, phosphorylated Tie2 and activated caspase-3 expressions in lung specimens were investigated. [Results ] Lung histological analysis in CHD with PAH groups exhibited endothelial cell hypertrophy and proliferation in the intima of pulmonary arterioles. The expression of Ang-1 and Tie2 was upregulated gradually in CHD with mild PAH group and CHD with moderate and severe PAH group. The phosphorylation of Tie2 was also increased gradually in the lungs of patients with PAH. But activated caspase-3 was severely reduced in the lungs of patients with PAH. [ Conclusions ] Decreased apoptosis of endothelial cells may be an essential part of the pathogenesis of congenital heart disease-induced pulmonary hypertension. Ang-1/Tie2 system may protect the pulmonary endothelium against apoptosis and promote the development of pulmonary arterial hypertension, while Ang-2 may have no significant effect on this process.
出处 《中国现代医学杂志》 CAS 北大核心 2015年第10期28-35,共8页 China Journal of Modern Medicine
基金 广东省科技计划项目(No:2013B021800315) 广州医科大学博士启动项目(No:2010C07)
关键词 血管生成素 TIE2 肺动脉高压 先天性心脏病 angiopoietin Tie2 pulmonary arterial hypertension congenital heart disease
  • 相关文献

参考文献29

  • 1MO RREL1 NW, ADNOT S, ARCHER SL, et al. Cellular and molecular basis of pulmonary arterial hypertension [J]. J Am Coil Cardiol, 2009, 54(1 Suppl): $20-$31.
  • 2RUDGE JS, THURSTON G, YANCOPOULOS GD. Angiopoietin-1 and pulmonary hypertension: cause or cure[J]. Circ Res, 2003, 92 (9): 947-949.
  • 3COHEN GM. Caspases: the executioners of apoptosis[J]. Bioehem J,1997, 326(Pt 1): 1-16.
  • 4LI~VY M, MAUREY C, CELERMAJER DS, et al.. Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease[J]. J Am Coil Cardiol, 2007, 49(7): 803-810.
  • 5DAVIS S, ALDRICH TH, JONES PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning[J]. Cell, 1996, 87(7): 1161-1169.
  • 6MAISONPIERRE C, SURI C, JONES PF, et al. Angiopoietin 2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J]. Science, 1997, 277(5322): 55-60.
  • 7RISAU W. Mechanisms of angiogenesis[J]. Nature, 1997, 386(6626): 671-674.
  • 8GRZENDA A, SHANNON J, FISHER J, et al. Timing and expression of the angiopoietin-l-Tie-2 pathway in murine lung development and congenital diaphragmatic hernia[J]. Dis Model Mech, 2013, 6(1): 106-114.
  • 9RONDELET B, KERBAUL F, VIVIAN GF, et al. Sitaxsentan for the prevention of experimental shunt-induced pulmonary hypertension[J]. Pediatr Res, 2007, 61(3): 284-288.
  • 10THISTLETHWAITEh PA, LEE SH, DU LL, et al. Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary tomy[J]. J Thorac Cardiovase Surg, 2001, 122(1): 65-73.

二级参考文献28

  • 1DAVIS S, ALDRICH TH, JONES PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning[J]. Cell, 1996, 87(7): 1161-1169.
  • 2MAISONPIERRE PC, SURI C, JONES PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis[J]. Science, 1997, 277(5322): 55-60.
  • 3VALENZUELA DM, GRIFFITHS JA, ROIAS 1, et al. Angiopoietins-3 and-4: diverging gene counterparts in mice and humans[J]. Proc Natl Acad Sci USA, 1999,96(5): 1904-1909.
  • 4SINGH H, TAHIR TA, ALAWO DO, et al. Molecular control of angiopoietin signalling [J]. Biochem Soc Trans, 2011, 39 (6): 1592- 1596.
  • 5SAHARINEN P and ALITALO K. The yin, the yang, and the angiopoietin-1[J]. J Clin Invest, 2011, 121(6): 2157-2159.
  • 6BURGER lA. Angiopoietin-2 in CLL[J]. Blood, 2010, 116(4): 508- 509.
  • 7MAKINDE T and AGRAWAL DK. Intra and extravascular transmembrane signalling of angiopoietin -1- Tie2 receptor in health and disease[J]. J Cell Mol Med, 2008, 12(3): 810-828.
  • 8RUDGE IS, THURSTON G and Y ANCOPOULOS GD. Angiopoietin -1 and pulmonar hypertension: cause or cure [J] Circ Res, 2003,92(9): 947-949.
  • 9DU L, SULLIVAN CC, CHU D, et al. Signaling molecules in nonfamilial pulmonary hypertension [J]. N Engl J Med, 2003, 348 (6): 500-509.
  • 10KIDO M, DU L, SULLIVAN CC, et al. Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents [J]. J Thorac Cardiovasc Surg, 2005, 129(2): 268-276.

共引文献1

同被引文献17

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部